Bluejay Diagnostics (BJDX) Other Non-Current Liabilities (2020 - 2026)
Bluejay Diagnostics recorded quarterly Other Non-Current Liabilities of $3489.0 in Q1 2026, down 23.15% quarter-over-quarter from $4540.0 in Q4 2025, and down 53.98% year-over-year from $7582.0 in Q1 2025.
Bluejay Diagnostics' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $3489.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 53.98% year-over-year to $3489.0; the TTM figure through Mar 2026 stood at $3489.0 (down 53.98% YoY), while the FY2025 annual figure was $4540.0, down 47.01% from the prior year.
- Other Non-Current Liabilities came in at $3489.0 for Q1 2026 at Bluejay Diagnostics, down from $4540.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $57588.0 in Q1 2024 to a low of $3489.0 in Q1 2026.
- A 5-year average of $13319.5 and a median of $10477.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities surged 284.69% in 2024 and plunged 86.83% in 2025, its largest moves.
- Bluejay Diagnostics' Other Non-Current Liabilities stood at $15823.0 in 2022, then fell by 22.13% to $12321.0 in 2023, then tumbled by 30.47% to $8567.0 in 2024, then tumbled by 47.01% to $4540.0 in 2025, then decreased by 23.15% to $3489.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3489.0, $4540.0, and $5573.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,489.00 |
| Dec 31, 2025 | 4,540.00 |
| Sep 30, 2025 | 5,573.00 |
| Jun 30, 2025 | 6,589.00 |
| Mar 31, 2025 | 7,582.00 |
| Dec 31, 2024 | 8,567.00 |
| Sep 30, 2024 | 9,530.00 |
| Jun 30, 2024 | 10,477.00 |
| Mar 31, 2024 | 57,588.00 |
| Dec 31, 2023 | 12,321.00 |
| Sep 30, 2023 | 13,220.00 |
| Jun 30, 2023 | 14,104.00 |
| Mar 31, 2023 | 14,970.00 |
| Dec 31, 2022 | 15,823.00 |
| Sep 30, 2022 | 15,420.00 |
| Dec 31, 2020 | 155,629.00 |